Your browser doesn't support javascript.
loading
Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells.
Rajendra Prasad, V V S; Deepak Reddy, G; Kathmann, Ietje; Amareswararao, M; Peters, G J.
Affiliation
  • Rajendra Prasad VV; Medicinal Chemistry Research Division, Vishnu Institute of Pharmaceutical Education and Research, Narsapur, India; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: rajendraprasad.vvs@viper.ac.in.
  • Deepak Reddy G; Medicinal Chemistry Research Division, Vishnu Institute of Pharmaceutical Education and Research, Narsapur, India.
  • Kathmann I; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Amareswararao M; Clinical Research Department, Emcure Pharmaceuticals Ltd., Pune, India.
  • Peters GJ; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Bioorg Chem ; 64: 51-8, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26657603
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Nitric Oxide Donors / Acridones / Antineoplastic Agents Limits: Humans Language: En Journal: Bioorg Chem Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Nitric Oxide Donors / Acridones / Antineoplastic Agents Limits: Humans Language: En Journal: Bioorg Chem Year: 2016 Type: Article